In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK. 

In this discussion, we cover the unpredictability of emerging markets and the unique challenges this presents. Ezgi also shares her future predictions for access in emerging markets and talks about the importance of cross-functional collaboration in pharma to support the ever-changing landscape. 

The opinions shared in this podcast are Ezgi's own views.   

Send us a text